Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia

NCT06957808 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT06957808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06957808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia
Lead sponsor
King's College London
Phase
Not applicable
Overall status
Recruiting
Start date
January 10, 2025
Completion date
January 20, 2027
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia disorders